Matches in SemOpenAlex for { <https://semopenalex.org/work/W2753994120> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2753994120 abstract "Background A significant prevalence of osteoarthritis (OA), the most disability joint disease in the world, which is important in the search for the new treatment. Analysis of modern therapy of OA was the reason for research efficacy of NSAIDs and SYSADOA on biochemical, inflammatory and immunological signs in the treatment of OA. Objectives Differentiated approach to the treatment of OA depending of presence of hyperuricemia. Methods 176 patients (144 women, 32 men) was exanimated, aged (59,71±0,86) years with confirmed radiographic OA according to Kellgren and Lawrence scale. Division into groups was performed depending on treatment. For 14 days group 1 (n=30) received nimesulide 100 mg twice daily, and group 2 (n=30) - meloxicam 15 mg 1 per day. For 6 months 3rd group (n=54) received diacerein 50 mg twice a day and the 4th group (n=32) - chondroitine sulfate (CS) 500 mg twice daily. 5th group (n=30) received glucosamine sulfate (GS) 400 mg 3 times per week for 1.5 months. It was estimated dynamics of VAS, WOMAC, Lequesne, uric acid (UA), CRP, IL-1β, IGF-1, NO, ESR, biochemical indicators. Statistical analysis - SPSS Statistics. Results Nimesulide compared to meloxicam found more effective for WOMAC index, the reduction of pain, stiffness and functional failure 53.93% vs 37.3%, 29.7% vs 13.5%, 41.6% vs 26.6% respectively. Only nimesulide decreased NO by 40.2%, and showed a decrease trend of UA from 375,33±24,6 to 321,57±19,6 mkmol/l while meloxicam had no effect on their levels. In 60% of patients with OA was found hyperuricemia with nephrolithiasis. Was showed the relation between the severity of OA and the presence of hyperuricemia by VAS, Lequesne, WOMAC, lesions more number joints, higher stage of X-ray progress. Diacerein, CS and GS showed clinical effect on pain reduction by VAS, Lequesne, WOMAC (p Conclusions Was showed that nimesulide is more effective than meloxicam during first 14 days, and reduces NO, an important proinflammatory factor. The presence of hyperuricemia in 60% patients with OA, resulted in a more severe OA. Diacerein decreases UA and glucose, given an advantage in treatment these patients, which isn9t presented with CS (which increased UA). References National Clinical Guideline Centre. Osteoarthritis. Clinical guideline CG177; 2014. Hyperuricemia and the risk for subclinical coronary atherosclerosis – data from a prospective observational cohort study. Krishnan E. et al. Arthritis Res. Ther. 2011;13(2):66. Disclosure of Interest None declared" @default.
- W2753994120 created "2017-09-25" @default.
- W2753994120 creator A5017596887 @default.
- W2753994120 creator A5055736998 @default.
- W2753994120 creator A5081449657 @default.
- W2753994120 creator A5087489304 @default.
- W2753994120 creator A5090279067 @default.
- W2753994120 date "2017-06-01" @default.
- W2753994120 modified "2023-09-27" @default.
- W2753994120 title "AB0812 Differentiated approach to the treatment of osteoarthritis with comorbidities" @default.
- W2753994120 doi "https://doi.org/10.1136/annrheumdis-2017-eular.3407" @default.
- W2753994120 hasPublicationYear "2017" @default.
- W2753994120 type Work @default.
- W2753994120 sameAs 2753994120 @default.
- W2753994120 citedByCount "0" @default.
- W2753994120 crossrefType "proceedings-article" @default.
- W2753994120 hasAuthorship W2753994120A5017596887 @default.
- W2753994120 hasAuthorship W2753994120A5055736998 @default.
- W2753994120 hasAuthorship W2753994120A5081449657 @default.
- W2753994120 hasAuthorship W2753994120A5087489304 @default.
- W2753994120 hasAuthorship W2753994120A5090279067 @default.
- W2753994120 hasBestOaLocation W27539941201 @default.
- W2753994120 hasConcept C105702510 @default.
- W2753994120 hasConcept C126322002 @default.
- W2753994120 hasConcept C142724271 @default.
- W2753994120 hasConcept C153074725 @default.
- W2753994120 hasConcept C170094789 @default.
- W2753994120 hasConcept C204787440 @default.
- W2753994120 hasConcept C2776164576 @default.
- W2753994120 hasConcept C2777570176 @default.
- W2753994120 hasConcept C2779286237 @default.
- W2753994120 hasConcept C2779553658 @default.
- W2753994120 hasConcept C2779721657 @default.
- W2753994120 hasConcept C2779751750 @default.
- W2753994120 hasConcept C2779881121 @default.
- W2753994120 hasConcept C71924100 @default.
- W2753994120 hasConcept C90924648 @default.
- W2753994120 hasConceptScore W2753994120C105702510 @default.
- W2753994120 hasConceptScore W2753994120C126322002 @default.
- W2753994120 hasConceptScore W2753994120C142724271 @default.
- W2753994120 hasConceptScore W2753994120C153074725 @default.
- W2753994120 hasConceptScore W2753994120C170094789 @default.
- W2753994120 hasConceptScore W2753994120C204787440 @default.
- W2753994120 hasConceptScore W2753994120C2776164576 @default.
- W2753994120 hasConceptScore W2753994120C2777570176 @default.
- W2753994120 hasConceptScore W2753994120C2779286237 @default.
- W2753994120 hasConceptScore W2753994120C2779553658 @default.
- W2753994120 hasConceptScore W2753994120C2779721657 @default.
- W2753994120 hasConceptScore W2753994120C2779751750 @default.
- W2753994120 hasConceptScore W2753994120C2779881121 @default.
- W2753994120 hasConceptScore W2753994120C71924100 @default.
- W2753994120 hasConceptScore W2753994120C90924648 @default.
- W2753994120 hasLocation W27539941201 @default.
- W2753994120 hasOpenAccess W2753994120 @default.
- W2753994120 hasPrimaryLocation W27539941201 @default.
- W2753994120 hasRelatedWork W1972837296 @default.
- W2753994120 hasRelatedWork W1986550093 @default.
- W2753994120 hasRelatedWork W1989989876 @default.
- W2753994120 hasRelatedWork W2102592796 @default.
- W2753994120 hasRelatedWork W2146807038 @default.
- W2753994120 hasRelatedWork W2157490742 @default.
- W2753994120 hasRelatedWork W2158395079 @default.
- W2753994120 hasRelatedWork W2317066930 @default.
- W2753994120 hasRelatedWork W2317723307 @default.
- W2753994120 hasRelatedWork W2354908485 @default.
- W2753994120 hasRelatedWork W2371332647 @default.
- W2753994120 hasRelatedWork W2375655143 @default.
- W2753994120 hasRelatedWork W2387752621 @default.
- W2753994120 hasRelatedWork W2393386383 @default.
- W2753994120 hasRelatedWork W2747157206 @default.
- W2753994120 hasRelatedWork W2945229269 @default.
- W2753994120 hasRelatedWork W2954616527 @default.
- W2753994120 hasRelatedWork W2990459172 @default.
- W2753994120 hasRelatedWork W3032752372 @default.
- W2753994120 hasRelatedWork W3125654355 @default.
- W2753994120 isParatext "false" @default.
- W2753994120 isRetracted "false" @default.
- W2753994120 magId "2753994120" @default.
- W2753994120 workType "article" @default.